Vocal fold scarring is a clinical problem without reliable treatment. Tissue engineering of a vocal fold replacement is an exciting potential treatment for vocal fold scars that involve multiple layers of the vocal fold. Human adipose-derived stem cells (ASC) were previously used to produce a promising vocal fold cover layer replacement. However, relevant in vivo studies are needed before human application, and implanting the human cells in animal larynges would introduce significant risk and data confounding. We therefore report here the development of a construct based on rabbit ASC with the potential for use in pre-clinical implantation studies. Rabbit ASC were isolated and cultured in a three-dimensional fibrin matrix to create an implantable construct resembling the vocal fold mucosa. Key differences between the human cell and the rabbit cell models are highlighted.
INTRODUCTION

Translating in vitro models
Von Kossa solution (5% AgNO 3 in distilled water) was used to detect osteogenic differentiation by staining calcium phosphate or calcium carbonate.
Sections were rinsed in distilled water for 5 minutes before applying Von Kossa solution and set beneath UV light for ten minutes. Sections were then rinsed in distilled water three times for 5 minutes each and counterstained with hematoxylin for one minute.
All samples were viewed and imaged the same day as staining using light microscopy with an EVOS XL inverted microscope (Life-Technologies). Fluorescence was viewed and imaged the same day as staining, with an Olympus microscope. Rabbit vocal fold sections were used as positive controls to confirm expected antibody reactivity.
Immunohistochemistry
RESULTS
Pluripotency of rabbit stromovascular fraction cells
Light microscopy demonstrated that cultures induced to differentiate into adipogenic and osteogenic cell types showed morphological changes after 2 weeks in culture (Fig. 1) . After 28 days in culture, induced cells showed positive staining for lipid after adipogenic culture ( Fig. 2A ) and mineral deposits after osteogenic culture ( For the constructs made with rabbit fibrinogen, hematoxylin and eosin microscopy showed a fibrin lattice with similar gross morphology to the vocal fold lamina propria and epithelium. Cell nuclei were identified throughout the construct (Fig. 4) . There was no observable morphologic difference between constructs treated with EGF and those that were not.
Differentiation of rabbit ASC in fibrin gel culture
Spontaneous differentiation to mesenchymal phenotypes did not occur. Histological staining using Oil
Red O and Von Kossa on tissue-engineered constructs in cultured for 14 days, with and without EGF treatment, showed negative staining for lipid and mineral (Fig. 5) .
Epithelial differentiation was not induced by EGF and an air interface in this rabbit ASC culture, as i n d i c a t e d b y i m m u n o h i s t o c h e m i s t r y .
Immunohistochemistry at 14 days was negative for cytokeratin. Vimentin, a general mesenchymal cell marker, was preserved in all cells with and without EGF exposure (Fig. 6 ). and increase elastin production, vocal fold smoothness and collagen organization 9, [21] [22] [23] [24] . Furthermore, adding a micronized acellular dermal matrix or hydrogel scaffold to the injection decreased scarring 9, 25 . The wound healing properties of ASC may be adequate to prevent scar formation after implantation, while the fibrin scaffold may further support ASC survival and differentiation. These aspects will be tested in a rabbit implantation trial. 
CONCLUSION
